LINDSEY MCCASKILL: Open Payments
NPI 1932751724 · LIVINGSTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 30 payments from 8 companies in 2025. Trend: 2023 $455 · 2024 $586 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $193 |
| Lilly USA, LLC | 5 | $87 |
| Novo Nordisk Inc | 3 | $54 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Corium, LLC | 2 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Lundbeck LLC | 1 | $22 |
Products named: VRAYLAR, MOUNJARO, QULIPTA, Ozempic, Auvelity, AIRSUPRA, Azstarys, CAPLYTA.
Industry payments across LA — which companies pay providers there.
